# Stem Cell Transplantation in Treating Patients With Hematologic Cancer

> **NCT00004904** · PHASE1 · COMPLETED · sponsor: **Northwestern University**

## Conditions studied

- Chronic Myeloproliferative Disorders
- Graft Versus Host Disease
- Leukemia
- Lymphoma
- Multiple Myeloma and Plasma Cell Neoplasm
- Myelodysplastic Syndromes
- Precancerous/Nonmalignant Condition
- Small Intestine Cancer

## Interventions

- **BIOLOGICAL:** anti-thymocyte globulin
- **BIOLOGICAL:** filgrastim
- **DRUG:** cladribine
- **DRUG:** cyclophosphamide
- **DRUG:** etoposide
- **DRUG:** methylprednisolone
- **DRUG:** tacrolimus
- **PROCEDURE:** allogeneic bone marrow transplantation
- **PROCEDURE:** in vitro-treated peripheral blood stem cell transplantation

## Key facts

- **NCT ID:** NCT00004904
- **Lead sponsor:** Northwestern University
- **Sponsor class:** OTHER
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 1999-10
- **Primary completion:** 2000-07
- **Final completion:** 2000-07
- **Target enrollment:** — (—)
- **Last updated:** 2012-06-04

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00004904

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00004904, "Stem Cell Transplantation in Treating Patients With Hematologic Cancer". Retrieved via AI Analytics 2026-06-04 from https://api.ai-analytics.org/clinical/NCT00004904. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*